Has Todd Rasner, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,568 in general payments to Todd Rasner, MD across 151 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Todd Rasner, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Todd Rasner, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Todd Rasner, MD

Gynecology · Jacksonville, FLNPI 1336148964

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.5% of the total across 151 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 16.1% — the pattern of someone who eats at a lot of different presentations.

$2,568in general payments, 2019–2025

Across 151 payments — averaging $17.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novo Nordisk$412
Hologic Sales And Service, LLC$305
Bayer$254
Therapeuticsmd, Inc.$228
AbbVie$151
Mayne Pharma Commercial LLC$140
plus $1K from 26 others

What the payments were for

Food & beverage$2,52898%
Education$402%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novo Nordisk	33	$412
Hologic Sales And Service, LLC	15	$305
Bayer	14	$254
Therapeuticsmd, Inc.	13	$228
AbbVie(2 entities)	8	$151
Mayne Pharma Commercial LLC	8	$140
Sumitomo Pharma America, Inc.	6	$115
Pfizer	7	$111
Millicent US Inc	5	$89
Shield Therapeutics Inc	2	$79
Lupin Inc.	3	$66
Lilly USA, LLC	4	$65
Coloplast	2	$53
Exeltis, USA Inc.	2	$42
AMAG Pharmaceuticals, Inc.	3	$40
Coopersurgical, Inc.	1	$38
Duchesnay USA Incorporated	2	$36
Endo Pharmaceuticals Inc.	2	$35
Covidien LP	2	$35
Amgen(2 entities)	2	$35
Astellas Pharma US Inc	2	$33
Virtus Pharmaceuticals LLC	2	$32
Agile Therapeutics, Inc.	2	$29
Avion Pharmaceuticals	2	$26
Solventum Corporation	1	$20
Vivus LLC	1	$18
Organon	2	$18
Myovant Sciences Inc.	1	$15
Scynexis, Inc.	1	$15
Exact Sciences	1	$13
Minerva Surgical, Inc	1	$12
Channel Medsystems, Inc.	1	$8

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Saxenda$100

How this compares

$2,568 in reported general payments places this provider in the 75th percentile of 290 gynecology providers in Florida.

See all gynecology providers in Florida →

Medicare billing

Part B allowed, 2024

$17,649

Medicare patients

Services billed

209

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
ProgesteroneProgesterone, Micronized	38	$1,106
Estradiol	29	$779
Medroxyprogesterone Acetate	20	$283
Spironolactone	17	$146

Paid to pharmacies, not to this prescriber.

Other gynecology in Jacksonville

Mary WechterJacksonville$4K
Kristin FernandezJacksonville$3K
Aileen CaceresKissimmee$406K
Parveen VahoraNew Port Richey$327K
James KondrupVenice$310K
Andrea GallowayThe Villages$252K
Jessica VaughtOrlando$129K
Steven ChavoustieMiami$113K
Marshall BovelskyMelbourne$52K
Minda NeimarkFt Lauderdale$46K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →